This page is optimized for a taller screen. Please rotate your device or increase the size of your browser window.

Comparing a medical records-based and a claims-based index for measuring comorbidity in patients with lung or colon cancer

Kenneth L. Kehl, Elizabeth B. Lamont, Barbara J. McNeil, Samuel R. Bozeman, Michael J. Kelley, Nancy L. Keating


April 16, 2015
Ascertaining comorbid conditions in cancer patients is important for research and clinical quality measurement, and is particularly important for understanding care and outcomes for older patients and those with multi-morbidity. The authors compared the medical records-based ACE-27 index and the claims-based Charlson index in predicting receipt of therapy and survival for lung and colon cancer patients.
North America